TABLE 2.

Basal fasting biochemical data before and after rosiglitazone therapy.

	Pre-rosiglitazone	Post-rosiglitazone	p
HbA1c (%)	6.7 ± 0.4%	7.2 ± 0.6%	0.23
Plasma Glucose (mM)	9.0 ± 0.9	7.9 ± 0.9	0.02
Insulin (pmol/L)	93.6 ± 13.8	71.4 ± 7.8	0.03
C-peptide (pmol/L)	0.83 ± 0.08	0.76 ± 0.06	0.19
Glucagon (ng/L)	87.0 ± 9.0	83.2 ± 7.3	0.54
Total Cholesterol (mM)	4.97 ± 0.39	5.43 ± 0.41	0.09
HDL Cholesterol (mM)	0.88 ± 0.05	0.96 ± 0.05	0.15
LDL Cholesterol (mM)	2.92 ± 0.34	3.31 ± 0.21	0.14
Triglycerides (mM)	6.31 ± 1.66	6.26 ± 1.34	0.97
Fatty acids (µmol/L)	497 ± 64	352 ± 55	0.003
Leptin (ng/ml)	21.1 ± 5.7	18.4 ± 4.7	0.34
Alkaline phosphatase(U/L)	72 ± 7	61 ± 7	0.007
γ–glutaryl transpeptidase (U/L)	29 ± 6	17 ± 3	0.001